Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T22:50:23.715Z.
Calculation as of: 2026-10-06T22:50:23.715Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 397c5a59cd83d044dab6d82224f034cfcc72b23d5b6e8de026e21d37d80d55f6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-11-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$198.33M
EV/EBITDA Ratio
N/A
TTM Avg
5.75x
3Y Avg
5.75x
5Y Avg
5.75x
Market Cap
$205.80M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$207.27M
EV/EBITDA Ratio
15.10x
TTM Avg
13.21x
3Y Avg
12.70x
5Y Avg
13.38x
Market Cap
$208.31M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $200.96M | N/A | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | N/A | 5.75x | 5.75x | 5.75x |
| Exagen Inc. (XGN)vs › | $197.87M | N/A | N/A | N/A | N/A |
| Surrozen, Inc. (SRZN)vs › | $197.18M | N/A | N/A | N/A | N/A |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.80M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $207.27M | 15.10x | 13.21x | 12.70x | 13.38x |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
| RxSight, Inc. (RXST)vs › | $192.49M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $209.91M | N/A | 6.24x | 9.83x | 9.83x |
| Entrada Therapeutics, Inc. (TRDA)vs › | $210.41M | N/A | 14.91x | 15.90x | 15.90x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2022-11-08 | 13.81x |
| 2022-11-07 | 13.52x |
| 2022-11-04 | 13.23x |
| 2022-11-03 | 13.87x |
| 2022-11-02 | 14.68x |
| 2022-11-01 | 15.21x |
| 2022-10-31 | 15.03x |
| 2022-10-28 | 15.66x |
| 2022-10-27 | 14.58x |
| 2022-10-26 | 14.85x |
| 2022-10-25 | 14.70x |
| 2022-10-24 | 14.13x |
| 2022-10-21 | 14.40x |
| 2022-10-20 | 14.15x |
| 2022-10-19 | 14.44x |
| 2022-10-18 | 15.03x |
| 2022-10-17 | 15.24x |
| 2022-10-14 | 13.74x |
| 2022-10-13 | 14.46x |
| 2022-10-12 | 14.40x |
| 2022-10-11 | 14.62x |
| 2022-10-10 | 13.87x |
| 2022-10-07 | 14.01x |
| 2022-10-06 | 14.89x |
| 2022-10-05 | 15.11x |
| 2022-10-04 | 15.72x |
| 2022-10-03 | 15.26x |
| 2022-09-30 | 15.54x |
| 2022-09-29 | 15.52x |
| 2022-09-28 | 15.60x |
| 2022-09-27 | 13.64x |
| 2022-09-26 | 13.05x |
| 2022-09-23 | 13.52x |
| 2022-09-22 | 14.23x |
| 2022-09-21 | 14.48x |
| 2022-09-20 | 15.17x |
| 2022-09-19 | 15.36x |
| 2022-09-16 | 15.09x |
| 2022-09-15 | 16.23x |
| 2022-09-14 | 15.97x |
| 2022-09-13 | 15.11x |
| 2022-09-12 | 16.93x |
| 2022-09-09 | 15.86x |
| 2022-09-08 | 18.54x |
| 2022-09-07 | 18.01x |
| 2022-09-06 | 16.40x |
| 2022-09-02 | 17.50x |
| 2022-09-01 | 18.11x |
| 2022-08-31 | 17.28x |
| 2022-08-30 | 17.77x |
| 2022-08-29 | 17.79x |
| 2022-08-26 | 18.21x |
| 2022-08-25 | 19.64x |
| 2022-08-24 | 19.60x |
| 2022-08-23 | 19.40x |
| 2022-08-22 | 19.17x |
| 2022-08-19 | 19.75x |
| 2022-08-18 | 20.28x |
| 2022-08-17 | 20.19x |
| 2022-08-16 | 21.05x |
| 2022-08-15 | 22.26x |
| 2022-08-12 | 22.87x |
| 2022-08-11 | 21.81x |
| 2022-08-10 | 22.48x |
| 2022-08-09 | 21.81x |
| 2022-08-08 | 22.71x |
| 2022-08-05 | 22.60x |
